SUBSCRIBE
SUBSCRIBE
News   FDA

Another Gastroesophageal Reflux Disease Drug Goes Generic by Matrix Laboratories Limited

January 26, 2011 | 
1 min read
MedPageToday -- WASHINGTON -- The FDA has approved a generic version of the pantoprazole delayed-release tablets (Protonix DR) to treat gastroesophageal reflux disease.
FDA Approvals
MORE ON THIS TOPIC
Two arrow signs representing the new way and old way approach to business
Policy
FDA disavows Makary, Prasad’s papers as lawmaker blasts ‘shoot-from-the-hip’ policymaking
July 17, 2026
 · 
3 min read
 · 
Tristan Manalac
Magnifying Glass Focused on Circuit Board with AI Word, Representing Artificial Intelligence and Technology Innovation.
Manufacturing
FDA’s first AI-focused cGMP warning letter signals new scrutiny for manufacturers
July 16, 2026
 · 
3 min read
 · 
John Potter
Silhouette of scuba diver, coral reef and underwater cave on a blue sea background. Vector nature illustration. Marine life.
Approvals
Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor
July 16, 2026
 · 
2 min read
 · 
Gabrielle Masson
Podcast
Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup
July 15, 2026
 · 
1 min read
 · 
Jef Akst